These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17666480)

  • 1. Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study.
    Völzke H; Friedrich N; Schipf S; Haring R; Lüdemann J; Nauck M; Dörr M; Brabant G; Wallaschofski H
    J Clin Endocrinol Metab; 2007 Oct; 92(10):4039-45. PubMed ID: 17666480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM; Khalid BA
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of socioeconomic status with iodine supply and thyroid disorders in northeast Germany.
    Völzke H; Craesmeyer C; Nauck M; Below H; Kramer A; John U; Baumeister S; Ittermann T
    Thyroid; 2013 Mar; 23(3):346-53. PubMed ID: 23317391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of thyroid hormones; insulin-like growth factor-1 (IGF-1), IGF binding proteins, and nutritional anthropometric parameters in school children with goiter detected by palpation.
    Ersoy B; Gunes HS; Uyanik BS; Taneli F; Gunay T
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):490-5. PubMed ID: 19876794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: results of the study of health in Pomerania (SHIP).
    Friedrich N; Rosskopf D; Brabant G; Völzke H; Nauck M; Wallaschofski H
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):266-73. PubMed ID: 19609846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.
    Friedrich N; Nauck M; Schipf S; Völzke H; Brabant G; Wallaschofski H
    Diabetes Metab Res Rev; 2013 Sep; 29(6):452-62. PubMed ID: 23576494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of thyroid disorders in adult type 1 diabetes mellitus.
    Völzke H; Krohn U; Wallaschofski H; Lüdemann J; John U; Kerner W
    Diabetes Metab Res Rev; 2007 Mar; 23(3):227-33. PubMed ID: 16906626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the insulin-like growth factor axis in serum and periodontitis in the Study of Health in Pomerania: an exploratory study.
    Harb AN; Holtfreter B; Friedrich N; Wallaschofski H; Nauck M; Albers M; Meisel P; Biffar R; Kocher T
    J Clin Periodontol; 2012 Oct; 39(10):931-9. PubMed ID: 22882716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
    Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
    Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S; Riggs BL; Atkinson EJ; Oberg AL; Melton LJ; Khosla S
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of IGF-I and the IGF-I/IGFBP-3 ratio with plasma aldosterone levels in the general population.
    Hannemann A; Wallaschofski H; Rettig R; Völzke H; Samietz S; Nauck M; Bidlingmaier M; Friedrich N
    Horm Metab Res; 2012 Mar; 44(3):228-33. PubMed ID: 22328165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
    Friedrich N; Haring R; Nauck M; Lüdemann J; Rosskopf D; Spilcke-Liss E; Felix SB; Dörr M; Brabant G; Völzke H; Wallaschofski H
    J Clin Endocrinol Metab; 2009 May; 94(5):1732-9. PubMed ID: 19223521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).
    Friedrich N; Alte D; Völzke H; Spilcke-Liss E; Lüdemann J; Lerch MM; Kohlmann T; Nauck M; Wallaschofski H
    Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP).
    Spilcke-Liss E; Friedrich N; Dörr M; Schminke U; Völzke H; Brabant G; Nauck M; Wallaschofski H
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):70-5. PubMed ID: 21521279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
    Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.